Skip to main content

Table 1 Patient baseline characteristics

From: Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant

Age (y), median (range)

62.5 (9–80)

Gender, n (%)

 

  Male

47 (75.8)

  Female

15 (24.2)

Indication of Liver Resection, n (%)

 

  Hepatocellular Carcinoma

23 (37.1)

  Colorectal Metastases

20 (32.3)

  Cholangiocarcinoma

13 (21.0)

  Other

6 (9.7)

Parenchymal Liver Disease, n (%)

 

  Fibrosis

21 (33.9)

  Steatosis

8 (12.9)

  Cholestasis

12 (19.4)

  None

21 (33.9)

Pre-Interventional Bilirubin, median (µmol/L)

10 (3-310)

Pre-Interventional Albumin, median (g/L)

38 (23–47)

Pre-Interventional INR, median

1.0 (0.9–1.3)

Diabetes Mellitus, n (%)

44 (71.0)